Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
Titel:
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
Auteur:
van Rossum, A.G.J. Kok, M. van Werkhoven, E. Opdam, M. Mandjes, I.A.M. van Leeuwen – Stok, A.E. van Tinteren, H. Imholz, A.L.T. Portielje, J.E.A. Bos, M.M.E.M. van Bochove, A. Wesseling, J. Rutgers, E.J. Linn, S.C. Oosterkamp, H.M.